Chemical Structure (Gabapenin 01)
Chemical structure of Gabapentin showing a cyclohexane ring with amino and carboxyl functional groups attached.*
Gabapentin Capsule
Product Images NDC 69367-345
8 FDA label images from Westminster Pharmaceuticals, Llc · Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 69367-345). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Westminster Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Gabapenin 02)
A line graph depicting mean pain score over time (weeks) for two groups during a 4-week dose titration period followed by a 4-week fixed dose period. The graph compares placebo and Gabapentin at 3,600 mg/day, showing a decrease in pain score for Gabapentin relative to placebo across baseline to week 8.*
Figure 2 (Gabapenin 03)
A line graph showing mean pain scores over a period of 7 weeks for three groups: placebo, Gabapentin 1,800 mg/day, and Gabapentin 2,400 mg/day. The x-axis represents weeks including a 3-week dose titration period and a 4-week fixed dose period, and the y-axis represents mean pain scores from 0 to 10.*
Figure 3 (Gabapenin 04)
A bar chart comparing the percentage outcomes of two studies involving Gabapentin (GBP) at different doses versus placebo (PBO). Study 1 shows 12% for placebo and 29% for Gabapentin 3600 mg. Study 2 shows 14% for placebo and 32% and 34% for Gabapentin 1800 mg and 2400 mg doses, respectively. Statistical significance is indicated with p-values.*
Figure 4 (Gabapenin 05)
A scatter plot chart comparing the percentage difference versus daily dose (mg) for Gabapentin in three distinct studies labeled as study a, study b, and study c. The x-axis represents daily dose in milligrams with values at 600, 900, 1,200, and 1,800 mg, and the y-axis shows the percentage difference ranging from 2% to 22%. The chart uses different shades of squares to differentiate between the three studies.*
Principal Display Panel (100 mg Capsule Bottle Label)
Label for Gabapentin Capsules, USP 100 mg, oral capsules, containing 100 capsules per container, labeled for Westminster Pharmaceuticals, LLC. The label includes storage instructions, manufacturing information with CSPC Ouyi Pharmaceutical Co., Ltd. as the manufacturer, and a note to dispense the Medication Guide to patients. The NDC is 69367-343-01.*
Principal Display Panel (300 mg Capsule Bottle Label)
Label for Gabapentin Capsules USP, 300 mg oral capsules, from Westminster Pharmaceuticals, LLC. The label indicates 100 capsules per container and includes handling instructions such as storing at 25°C with permitted excursions. It features the NDC 69367-344-01, a pharmacist note to dispense a medication guide, and manufacturer information for CSPC Ouyi Pharmaceutical Co., Ltd.*
Principal Display Panel (400 mg Capsule Bottle Label)
Label for Gabapentin Capsules USP, 400 mg strength, oral capsules. The label states the product is manufactured by CSPC Ouyi Pharmaceutical Co., Ltd. in China and labeled for Westminster Pharmaceuticals, LLC. It contains 100 capsules and includes storage instructions. The NDC number 69367-345-01 and child-resistant container information are present.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
